Patents by Inventor Safall Fall

Safall Fall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9220296
    Abstract: A method for reducing the tobacco specific nitrosamines (TSNAs) in tobacco and tobacco smoke is provided. The tobacco is combined with a solvent to form a soluble extracts fraction and an insoluble residue fraction. The soluble extracts fraction is contacted with a nitrosamine-reducing material to provide a soluble extracts fraction having a reduced level of TSNAs. The nitrosamine-reducing material may comprise a sepiolite. The insoluble residue fraction is contacted with an alkali extractant to provide an insoluble residue fraction having a reduced level of TSNAs. The alkali extractant may comprise a hydroxide. The soluble extracts fraction having a reduced level of TSNAs and insoluble residue fraction having a reduced level of TSNAs may be recombined to form a reconstituted tobacco product having a reduced level of TSNAs. The TSNAs may be reduced by at least about 30%, such as at least about 40%, such as at least about 50%.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 29, 2015
    Inventors: Safall Fall, Nathalie Durot, Solen Prime, Francois-Marie Robin
  • Publication number: 20140261482
    Abstract: A method for reducing the tobacco specific nitrosamines (TSNAs) in tobacco and tobacco smoke is provided. The tobacco is combined with a solvent to form a soluble extracts fraction and an insoluble residue fraction. The soluble extracts fraction is contacted with a nitrosamine-reducing material to provide a soluble extracts fraction having a reduced level of TSNAs. The nitrosamine-reducing material may comprise a sepiolite. The insoluble residue fraction is contacted with an alkali extractant to provide an insoluble residue fraction having a reduced level of TSNAs. The alkali extractant may comprise a hydroxide. The soluble extracts fraction having a reduced level of TSNAs and insoluble residue fraction having a reduced level of TSNAs may be recombined to form a reconstituted tobacco product having a reduced level of TSNAs. The TSNAs may be reduced by at least about 30%, such as at least about 40%, such as at least about 50%.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Safall Fall, Nathalie Durot, Solen Prime, Francois-Marie Robin